Sign in

CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company

ACHIEVE LIFE SCIENCES, INC.

Sign in to watch
Ticker
ACHV
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
954343413
Phone
425-686-1500
Business address
22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
Former names
ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
  1. SC 13G Stake Amended Statement of Ownership
  2. 8-K Event Delisting notice
  3. 4 Insider Changes in Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. SC 13G Stake Amended Statement of Ownership
  7. 4 Open-market buy CEO bought 22,000 shares
  8. 8-K Event Material agreement · Unregistered share sale · Other events
  9. 10-Q Report Quarterly Report
  10. 8-K Event Results of operations
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award CEO acquired 3,059 shares (grant or award)
  15. 4 Grant or award President & CMO acquired 1,817 shares (grant or award)
  16. 4 Grant or award Principal Accounting Officer acquired 2,827 shares (grant or award)
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 68 · 1,358 filings